TASS3y
Over 90% inoculated with EpiVacCorona jab developed COVID-19 antibodies, says researcher
EpiVacCorona, developed by the Russian sanitary watchdog’s State Research Center of Virology and Biotechnology Vector, is Russia’s second coronavirus vaccine MOSCOW, May 5. /TASS/. More than ...
BioSpace2d
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
FiercePharma4d
Novartis debuts €40M viral vector plant in Slovenia, part of €3.5B investment push in the country
Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 ...
Baylor College of Medicine4y
Vector Biology and Bacterial Pathogens Lab
This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...
TASS3y
Over three mln doses of EpiVacCorona vaccine produced in 2021
EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, June 11. /TASS/. Over three mln doses ...